WELCOME

NDC	HCPCS	HCPCS Description	NDC Label	Route of Administration
38779-0925-08	J3360	INJECTION, DIAZEPAM, UP TO 5 MG	DIAZEPAM (U.S.P.)	NA
38779-0925-09	J3360	INJECTION, DIAZEPAM, UP TO 5 MG	DIAZEPAM (U.S.P.)	NA
38779-0927-01	J2060	INJECTION, LORAZEPAM, 2 MG	LORAZEPAM (U.S.P.)	NA
38779-0927-03	J2060	INJECTION, LORAZEPAM, 2 MG	LORAZEPAM (U.S.P.)	NA
38779-0927-04	J2060	INJECTION, LORAZEPAM, 2 MG	LORAZEPAM (U.S.P.)	NA
38779-0927-05	J2060	INJECTION, LORAZEPAM, 2 MG	LORAZEPAM (U.S.P.)	NA
38779-0927-06	J2060	INJECTION, LORAZEPAM, 2 MG	LORAZEPAM (U.S.P.)	NA
38779-0927-08	J2060	INJECTION, LORAZEPAM, 2 MG	LORAZEPAM (U.S.P.)	NA
38779-0944-07	J0270	INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)	ALPROSTADIL (U.S.P.)	NA
38779-0944-09	J0270	INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)	ALPROSTADIL (U.S.P.)	NA
16714-0834-01	J2469	INJECTION, PALONOSETRON HCL, 25 MCG	PALONOSETRON HCL 0.05 MG/1 ML	IV
16714-0856-01	Q2050	INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10 MG	DOXORUBICIN HCL LIPOSOME 2 MG/1 ML	IV

HCPCS Code	Description	Billing Unit	SA Type
A7005	Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable	Each	N
A7006	Administration set, with small volume filter pneumatic nebulizer	Each	N
A7007	Large voume nebulizer, disposable, unfilled, used with aerosol compressor	Each	N
A7008	Large volume nebulizer, disposable, Prefilled, used with aerosol compressor	Each	N